跳至主要内容
临床试验/NCT07273110
NCT07273110已完成不适用

Effectiveness of Extracorporeal Shock Wave Therapy in Patellofemoral Pain Syndrome: A Randomized Controlled Trial

Uğur Can Yalaki2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2021年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
2
主要终点
Visual Analogue Scale, 0-10

研究概览

简要总结

Patellofemoral pain syndrome (PFPS) is a common cause of anterior knee pain and functional limitations in physically active individuals. Exercise-based rehabilitation is considered the primary treatment approach, yet a proportion of patients experience persistent symptoms. Extracorporeal shock wave therapy (ESWT) is a non-invasive modality that may reduce pain through neuromodulation and tissue-level biological responses.

This randomized controlled trial evaluated the effects of ESWT on knee pain and function in adults with PFPS. Thirty-six participants aged 18-45 years were randomly assigned to one of three groups: Exercise, Exercise plus ESWT, or ESWT alone. The exercise program consisted of home-based hip and knee strengthening performed at least three times per week for four weeks. ESWT was administered as five radial shock wave sessions at five-day intervals around the peripatellar soft tissues.

Outcomes included worst knee pain measured by the Visual Analogue Scale and functional status measured by the Kujala Patellofemoral Score at baseline, week 1, and week 8. All groups demonstrated significant improvements over time, with no significant differences between groups. The treatment was well tolerated.

This trial was retrospectively registered after patient enrollment was completed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 45 years.
  • Clinical diagnosis of patellofemoral pain syndrome (PFPS) characterized by anterior or retropatellar knee pain lasting at least 8 weeks.
  • Pain provoked during at least two of the following activities: running, jumping, squatting, stair climbing, or prolonged sitting.
  • Worst knee pain score of ≥3 on the Visual Analog Scale (0-10).
  • Ability to understand and follow the exercise program and assessment procedures.
  • Provided written informed consent.

排除标准

  • Evidence of intra-articular knee pathology other than grade 1-2 meniscal changes or grade 1 chondromalacia patella on MRI.
  • Clinical signs of patellar instability.
  • Localized tenderness indicating alternative diagnoses (e.g., patellar tendinopathy, iliotibial band syndrome, pes anserine bursitis).
  • History of knee surgery on the affected side.
  • Intra-articular injections (e.g., corticosteroids, hyaluronic acid, PRP) within the past 6 months.
  • Neurological or rheumatological disorders affecting the lower extremity.
  • Active infection, open wound, tumor, or severe dermatological condition at or near the ESWT application site.
  • Pregnancy.

结局指标

主要结局

Visual Analogue Scale, 0-10

时间窗: Baseline, Week 1, Week 8

The Visual Analog Scale (VAS) was used to assess the worst knee pain experienced in the previous week during daily or functional activities. Participants rated their pain on a 0-10 scale, where 0 represents no pain and 10 represents the worst imaginable pain. Pain intensity was recorded at baseline prior to intervention, at one week, and at eight weeks after the treatment to evaluate short- and mid-term treatment effects.

次要结局

  • Kujala Patellofemoral Score(Baseline, Week 1, Week 8)

研究者

发起方
Uğur Can Yalaki
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Uğur Can Yalaki

MD

Uludag University

研究点 (2)

Loading locations...

相似试验